x Lorea
You move the numbers.
Ours move with them.
We told you the shape of this on page one: go hard for 120 days, then price the next thing on evidence. Here it is in three structures. We haven't forecast your results anywhere on this page. The two figures driving every number below are yours to set, and we'd rather argue about them now than discover we disagreed in January.
Your non-THC line launches inside these 120 days.
The single biggest thing we can do about December 11 is make sure it isn't the only door. So the compliant sub-0.4mg line ships as part of this engagement: formulation brief, labelling, photography, PDPs, mood architecture carried across, subscription logic, and the launch sequence to the list we're building for you in the meantime.
Same moods. Same ritual. Same design language. Ready to sell before the deadline rather than scrambled after it. And if the full-dose line keeps its lane, you've simply added a second one.
The two numbers we'd be paid on
These are yours to set, not ours to predict. Move them to whatever you think is realistic, pessimistic, ambitious, or somewhere in between, and every figure on this page follows.
across the window$250K
on the book at December 31125
to you, lifetime$300
What each structure asks of you, across every outcome
Rather than pick one result and build a case on it, this shows all three structures across the full range. Where a line sits low, that structure asks less of you. Where it climbs, we're being paid because something worked. The marker is where you've set the sliders.
Paid on both the flow and the asset: a smaller share of new revenue, plus a smaller bounty on every subscriber. It's the only structure here that pays us for building the thing that survives December, which is exactly why it's the one we'd pick. A subscriber on your book on January 1 is worth more to Lorea than a good month in October, and our compensation should say so.
monthly$12,000
Set by the two levers below. Take either one down and this goes up.
monthly$6,000
Set by the lever below. Take the share down and this goes up.
monthly$18,000
Set by the lever below. Take the bounty down and this goes up.
How this works, whichever one you pick
New revenue only
The share never touches revenue you already have. It applies above your current run rate, so you're never paying us for work we didn't do.
One set of numbers
We read from your Shopify and Klaviyo directly and send one statement a month. No attribution arguments, no competing dashboards.
Nothing capped
We don't cap our upside and we don't ask you to cap yours. If this works better than either of us expects, we both find out at the same time.
A door out
If the December rules land in a way that changes the business, either side can step out on thirty days. You shouldn't be paying for a plan that stopped being the plan.